Guided Therapeutics (GTHP) Return on Sales Growth (5y) (2015 - 2025)
Guided Therapeutics (GTHP) Return on Sales Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn |
| 10 | Guided Therapeutics | 20.39 Mn | 20.32 Mn | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -89.00 |
| Sep 30, 2025 | -33.00 |
| Jun 30, 2025 | 173.00 |
| Mar 31, 2025 | -2,499.00 |
| Dec 31, 2024 | -720.00 |
| Sep 30, 2024 | 69.00 |
| Jun 30, 2024 | 2,606.00 |
| Mar 31, 2024 | -55.00 |
| Dec 31, 2023 | 53.00 |
| Sep 30, 2023 | 299.00 |
| Jun 30, 2023 | -463.00 |
| Mar 31, 2023 | -310.00 |
| Dec 31, 2022 | -252.00 |
| Sep 30, 2022 | -296.00 |
| Jun 30, 2022 | -173.00 |
| Mar 31, 2022 | -96.00 |
| Dec 31, 2021 | -12.00 |
| Sep 30, 2021 | 6.00 |
| Dec 31, 2020 | 282.00 |
| Sep 30, 2020 | 294.00 |